Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2006.081257v1, 2007; 10.1373/clinchem.2006.081257
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2006.081257v1
53/4/686    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chang, Y.
Right arrow Articles by Jang, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chang, Y.
Right arrow Articles by Jang, Y.

Received on October 3, 2006
Accepted on January 8, 2007

Lipids, Lipoproteins, and Cardiovascular Risk Factors

Higher Concentrations of Alanine Aminotransferase within the Reference Interval Predict Nonalcoholic Fatty Liver Disease

Yoosoo Chang 1, Seungho Ryu 2*, Eunju Sung 3, Yumi Jang 4

1 Health Screening Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
2 Department of Occupational Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
3 Department of Department of Family Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
4 Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Ulsan, Korea

* To whom correspondence should be addressed. E-mail: sh703.yoo{at}samsung.com.

Background: In nonalcoholic fatty liver disease (NAFLD), increased alanine aminotransferase (ALT) concentrations are considered to be a consequence of hepatocyte damage. We performed a prospective study to examine the association between ALT within its reference interval and risk for subsequent development of NAFLD.

Methods: The study cohort comprised 5237 healthy men without diagnosed NAFLD and without increases of either ALT (≥35 U/L) or {gamma}-glutamyltransferase (GGT; ≥40 U/L) above the reference intervals. We assessed alcohol intake via self-reporting (questionnaire) and performed biochemical tests for liver and metabolic function and abdominal ultrasonography. We used the Cox proportional hazards model to calculate the adjusted hazard ratios (aHRs) in the model for NAFLD.

Results: During 13 276.6 person-years of follow-up over a 4-year period, 984 new incident cases of NAFLD developed. We adjusted for age, weight change, body mass index, glucose, blood pressure, triglycerides, HDL cholesterol, smoking, alcohol consumption, regular exercise, homeostasis model assessment of insulin resistance, C-reactive protein, and incident diabetes. Compared with an ALT concentration of <16 U/L, aHR values (95% confidence intervals) for ALT concentrations were 1.53 (1.18-1.98), 1.66 (1.29-2.13), 1.62 (1.26-2.08), and 2.21 (1.73-2.81) for ALT concentrations of 16-18, 19-21, 22-25, and 26-34 U/L, respectively. This relationship remained significant even among normal-weight participants who were still within the reference interval of ALT and GGT at all follow-up examinations.

Conclusions: In apparently healthy, nondiabetic Korean men, increased ALT concentration, even within the reference interval, was an independent predictor of incident NAFLD.




The following articles in journals at HighWire Press have cited this article:


Home page
Arch Intern MedHome page
B. A. Neuschwander-Tetri, A. Unalp, M. H. Creer, and for the Nonalcoholic Steatohepatitis Clinical Rese
Influence of Local Reference Populations on Upper Limits of Normal for Serum Alanine Aminotransferase Levels
Arch Intern Med, March 24, 2008; 168(6): 663 - 666.
[Full Text] [PDF]


Home page
Diabetes CareHome page
G. Musso, R. Gambino, S. Bo, B. Uberti, G. Biroli, G. Pagano, and M. Cassader
Should Nonalcoholic Fatty Liver Disease Be Included in the Definition of Metabolic Syndrome?: A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects
Diabetes Care, March 1, 2008; 31(3): 562 - 568.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
G. Musso, R. Gambino, F. De Michieli, G. Biroli, A. Premoli, G. Pagano, S. Bo, M. Durazzo, and M. Cassader
Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: possible role of vitamin A intake
Am. J. Clinical Nutrition, September 1, 2007; 86(3): 661 - 671.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Gomez-Ambrosi, V. Catalan, B. Ramirez, A. Rodriguez, I. Colina, C. Silva, F. Rotellar, C. Mugueta, M. J. Gil, J. A. Cienfuegos, et al.
Plasma Osteopontin Levels and Expression in Adipose Tissue Are Increased in Obesity
J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3719 - 3727.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
G. Targher, M. Franchini, G. C. Guidi, M. Muggeo, and G. Lippi
Alanine Aminotransferase as an Independent Predictor of Incident Nonalcoholic Fatty Liver Disease
Clin. Chem., June 1, 2007; 53(6): 1159 - 1159.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
Y. Chang, S. Ryu, E. Sung, and Y. Jang
Reply to Alanine Aminotransferase as an Independent Predictor of Incident Nonalcoholic Fatty Liver Disease
Clin. Chem., June 1, 2007; 53(6): 1159 - 1161.
[Full Text] [PDF]

eLetters:

Read all eLetters

Alanine aminotransferase as an independent predictor of incident nonalcoholic fatty liver disease
Giovanni Targher, et al.
Clinical Chemistry Online, 10 Feb 2007 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American Association for Clinical Chemistry.